-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Insmed, Raises Price Target to $269

Benzinga·12/11/2025 16:48:43
Listen to the news
TD Cowen analyst Ritu Baral maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $231 to $269.